Comparative study of prevalence of metabolic syndrome in bipolar disorder and schizophrenia from North India

Nordic Journal of Psychiatry

Volumn 68, Issue 1, 2014, Pages 72-77

  Grover, Sandeep ^a   Nebhinani, Naresh ^a   Chakrabarti, Subho ^a   Avasthi, Ajit ^a   Kulhara, Parmanand ^a   Basu, Debasish ^a   Mattoo, Surendra Kumar ^a   Malhotra, Savita ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Bipolar disorder; India; Metabolic syndrome; Prevalence; Schizophrenia

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CARBAMAZEPINE; CHLORPROMAZINE; CLONAZEPAM; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; LORAZEPAM; NITRAZEPAM; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; SULPIRIDE; TRIFLUOPERAZINE; VALPROIC ACID; ZIPRASIDONE; ZOLPIDEM; ZOPICLONE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTICONVULSANT THERAPY; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; EMPLOYMENT STATUS; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MARRIED PERSON; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NUCLEAR FAMILY; PARANOIA; PREVALENCE; SCHIZOPHRENIA; YOUNG ADULT;

ADULT; BIPOLAR DISORDER; CHOLESTEROL; CONTROL GROUPS; FEMALE; HUMANS; INDIA; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; SCHIZOPHRENIA; SOCIOECONOMIC FACTORS; TERTIARY CARE CENTERS;

EID: 84891099328     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.3109/08039488.2012.754052     Document Type: Article

References (41)

1. Basu R, Brar JS, Chengappa KN, John V, Parepally H, Gershon S, et al . The prevalence of the metabolic syndrome in patients with schizoaffective disorder-bipolar subtype . Bipolar Disord 2004 ; 6 : 314-318 (Pubitemid 39077092)
2. Chang HH, Chou CH, Chen PS, Gean PW, Huang HC, et al . High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan . J Affect Disord 2009 ; 117 : 124-129
3. Correll CU, Frederickson AM, Kane JM, Manu P . Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics . Bipolar Disord 2008 ; 10 : 788-797
4. D'Mello DA, Narang S, Agredano G . Prevalence and Consequences of Metabolic Syndrome in Bipolar Disorder . Psychiat Times 2007; 24 : 1
5. Elmslie JL, Porter RJ, Joyce PR, Hunt PJ, Shand BI, Scott RS . Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls . Aust N Z J Psychiatry 2009 ; 43 : 53-60
6. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ . Metabolic syndrome in bipolar disorder: Findings from the Bipolar Disorder Centre for Pennsylvanians . Bipolar Disord 2005 ; 7 : 424-30 (Pubitemid 41419409)
7. Fiedorowicz JG, Palagummi NM, Forman-Hoffman VL, Miller DD, Haynes WG . Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder . Ann Clin Psychiatry 2008 ; 20 : 131-137 (Pubitemid 352009283)
8. Garcia-Portilla MP, Saiz PA, Benabarre A, Sierra P, Perez J, Rodriguez A, et al . The prevalence of metabolic syndrome in patients with bipolar disorder . J Affect Disord 2008 ; 106 : 197-201 (Pubitemid 350309669)
9. Grover S, Aggarwal M, Chakrabarti S, Dutt A, Avasthi A, Kulhara P, et al . Prevalence of metabolic syndrome in bipolar disorder: An exploratory study from North India . Prog Neuropsychopharmacol Biol Psychiatry 2012; 36: 141-146
10. Guerreiro DF, Navarro R, Telles-Correia D, Martins P, Trigo E, Silva M . Effectivity of screening, concepts and attitudes towards metabolic syndrome: A study in bipolar patients followed in hospital Santa Maria psychiatric consultation. Acta Med Port 2010; 23: 173-182
11. John AP, Koloth R, Dragovic M, Lim SC . Prevalence of metabolic syndrome among Australians with severe mental illness . Med J Australia 2009 ; 190 : 176-179
12. Kemp DE, Calabrese JR, Tran QV, Pikalov, A, Eudicone JM, Baker RA . Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder: A post hoc analysis of a randomized, double-blind, placebo-controlled trial . J Clin Psychiatry 2010 ; 71 : 1138-1144
13. Maina G, D ' Ambrosio V, Aguglia A, Paschetta E, Salvi V, Bogetto F . Bipolar disorders and metabolic syndrome: A clinical study in 185 patients . Riv Psichiatr 2010 ; 45 : 34-40
14. Salvi V, Albert U, Chiarle A, Soreca I, Bogetto F, Maina G . Metabolic syndrome in Italian patients with bipolar disorder . Gen Hosp Psychiatry 2 008; 3 0: 3 18-3 23 (Pubitemid 351863767)
15. Sicras A, Rejas J, Navarro R, Serrat J, Blanca M . Metabolic syndrome in bipolar disorder: A cross-sectional assessment of a Health Management Organization database. Bipolar Disord 2008; 10: 607-616 (Pubitemid 352003828)
16. Teixeira PJ, Rocha FL . The prevalence of metabolic syndrome among psychiatric inpatients in Brazil . Rev Bras Psiquiatr 2007 ; 29 : 330-336 (Pubitemid 351358057)
17. Van Winkel R, De Hert M, Van Eyck D, Hanssens L, Wampers M, Scheen A, et al . Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder . Bipolar Disord 2008 ; 10 : 342-348 (Pubitemid 351637699)
18. Van Winkel R, Van Os J, Celic I, Van Eyck D, Wampers M, Scheen A, et al . Psychiatric diagnosis as an independent risk factor for metabolic disturbances: Results from a comprehensive, naturalistic screening program. J Clin Psychiatry 2 008; 6 9: 1 319-1 327
19. Vuksan-Cusa B, Marcinko D, Nad S, Jakovljevi M . Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts . Prog Neuropsychopharmacol Biol Psychiatry 2009 ; 33 : 109-112
20. Yumru M, Savas HA, Kurt E, Kaya MC, Selek S, Savas E, et al . Atypical antipsychotics related metabolic Syndrome in bipolar patients . J Affect Dis 2007 ; 98 : 247-252 (Pubitemid 46151723)
21. Chang HH, Yang YK, Gean PW, Huang HC, Chen PS, Lu RB . The role of valproate in metabolic disturbances in bipolar disorder patients . J Affect Dis 2010 ; 124 : 319-323
22. Bowden DW, Rudoc M, Ziegler J, Lehtinen AB, Xu J, Wagenknecht LE, et al . Coincident linkage of Type 2 diabetes, metabolic syndrome and measures of cardiovascular disease in a genome scan of the diabetes heart study . Diabetes 2006; 55: 1985-1994 (Pubitemid 44509971)
23. De Hert MA, vanWinkel R, van Eyck D, Hanssens L, Wampers M, Scheen A, et al . Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication . Schizophr Res 2006 ; 83 : 87-93
24. De Hert M, Schreurs V, Sweers K, Van Eyck D, Hanssens L, Sinko S, et al . Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review . Schizophr Res 2008 ; 101 : 295-303
25. Correll CU, Frederickson AM, Kane JM, Manu P . Does antipsychotic polypharmacy increase the risk for metabolic syndrome? Schizophr Res 2 007; 8 9: 9 1-1 00 (Pubitemid 44881290)
26. Hasnain M, Fredrickson SK, Vieweg WV, Pandurangi AK . Metabolic syndrome associated with schizophrenia and atypical antipsychotics . C ur Diabetes Rep 2 010; 1 0: 2 09-2 16
27. McEvoy JP, Mayer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, et al . Prevalence of metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005; 80: 19-32 (Pubitemid 41587460)
28. Allison DB, Newcomer JN, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, et al. Obesity among those with mental disorders: A National Institute of Mental Health Meeting Report . Am Prev Med 2009; 36: 341-350
29. Limosin F, Gasquet I, Leguay D . Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia . Acta Psychiat Scand 2008 ; 118 : 19-25 (Pubitemid 351832023)
30. World Health Organization: The ICD-10 classification of mental and behavioural disorders -Clinical descriptions. and diagnostic guidelines . Geneva: WHO; 1992
31. Alberti KG, Zimmet P, Shaw J . Metabolic syndrome -A new worldwide definition . A Consensus Statement from the International Diabetes Federation. Diabetic Med 2005 ; 23 : 469-480
32. Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) . JAMA 2001 ; 285 : 2486-2497
33. Tan CE, Ma S, Wai D, Chew SK, Tai ES . Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27: 1182-1186 (Pubitemid 38579787)
34. Misra A, Wasir JS, Pandey RM . An evaluation of candidate definitions of the metabolic syndrome in adult Asian Indians . Diabetes Care 2005; 28: 398-403 (Pubitemid 40170946)
35. Sahoo S, Ameen S, Akhtar S . Incidence of new onset metabolic syndrome with atypical antipsychotics in first episode schizophrenia: A six week prospective study in Indian female patients . Schizophr Res 2007; 95: 247 (Pubitemid 47313636)
36. Sahoo S, Narayana M, Shahul A, Sayeed A . Metabolic syndrome in first episode schizophrenia: A randomized double-blind controlled short-term prospective study . Schizophr Res 2008 ; 101 : 266-272
37. Padmawati R, McCreadle RG, Tirupati S . Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia . Schizophr Res 2010; 121: 199-202
38. Grover S, Nebhinani N, Chakrabarti S, Parakh P, Ghormode D . Metabolic syndrome in antipsychotic na ï ve patient diagnosed with schizophrenia . Early Interv Psychiatry 2012 ; 6 : 326-331
39. Grover S, Nebhinani N, Chakrabarti S, Avasthi A, Kulhara P . Prevalence of metabolic syndrome in subjects receiving clozapine: A study from India . Indian J Pharmacology 2011 ; 43 : 591-595
40. Bond DJ, Kunz M, Torres IJ, Lam RW, Yatham LN . The association of weight gain with mood symptoms and functional outcomes following a first manic episode: Prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). Bipolar Disord 2010; 12: 616-626
41. De Hert M, Detraux J, van Winkel R, Yu W, Correll CU . Metabolic and cardiovascular adverse effects associated with antipsychotic drugs . Nat Rev Endocrinol 2011 ; 8 : 114-126.